Physician profile
Michael Cooney
NPI 1942221460
$1,940.85
in general payments reported to CMS, 2019-2025
19 companies · $533 in 2025
The $533 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $63.89 · 2021: $401 · 2022: $128 · 2023: $265 · 2024: $176 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $974.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $835.33 | 2019-2025 | Mako, Tornier Perform Reversed Glenoid, Gamma |
| Smith+Nephew, INC. | $260.83 | 2019-2024 | Pico 14, Evos |
| Kyocera Medical Technologies, INC. | $178.70 | 2023 | |
| Heron Therapeutics, INC. | $121.84 | 2025 | Zynrelef, Aponvie |
| Southern Edge Orthopaedics, INC. | $95.89 | 2022-2025 | |
| Bioventus LLC | $85.90 | 2019-2025 | Xcell, Gelsyn-3 |
| Royal Biologics, INC. | $56.48 | 2025 | |
| Globus Medical, INC. | $49.97 | 2021 | |
| Ermi LLC | $47.02 | 2022 | |
| Depuy Synthes Sales INC. | $40.18 | 2021-2023 | Orthovisc, Monovisc |
| Heraeus Medical, LLC. | $26.18 | 2020-2021 | |
| Vericel Corporation | $23.33 | 2021 | |
| Avanos Medical | $22.95 | 2024 | Trivisc Sodium Hyaluronate |
| Genentech USA, INC. | $19.91 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.08 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $16.47 | 2021 | |
| Pfizer INC. | $15.34 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.59 | 2022 | |
| Dynasplint Systems INC. | $12.86 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cooney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.